Call Today: (800) 639-7580
Submit your Avandia claim details for a free, no obligation case review
Get Started:
Avandia settlements attempt to compensate patients for the severe injuries they sustain after taking Avandia, a tablet medication prescribed to treat type-2 diabetes.
Produced by GlaxoSmithKline, Avandia is generically known as rosiglitazone and has been available in the U.S. since 1999. Despite being effective at regulating an individual's blood sugar levels, however, Avandia has been reported to cause some severe, potentially fatal side effects, including:
Avandia patients who develop such serious injuries should:
To date, the Food and Drug Administration (FDA) has not issued an Avandia recall. However, in May 2007, the FDA:
These actions came on the heels of research, published in the Heart medical journal that suggested that Avandia can increase the likelihood of having a heart attack by up to 40 percent.
In addition to listing severe Avandia side effects, the black box warnings on Avandia also highlight some factors that may increase the risks of developing such health complications. Risk factors for serious Avandia side effects include having a history of:
To minimize the risk of developing severe Avandia side effects, it's essential that diabetes patients discuss their complete medical history with their doctor before starting a course of this medication.
Patients injured after taking Avandia will likely have a legal claim against GlaxoSmithKline and will be entitled to an Avandia settlement for their injuries and losses.
Prospective plaintiffs can find out more about their legal rights by consulting an experienced defective drug attorney for a free initial consultation. Along with getting a thorough evaluation of their claim, injured parties can also get expert legal advice regarding the best manner in which to pursue their case.
To schedule a private, free consultation to see whether you qualify for a settlement, contact a qualified Avandia settlement legal professional today.
A government run diabetes trial was halted 18 months early after a safety analysis revealed an increased risk of death in patients whose blood sugar levels dipped too low.
The 10,000 patient trial was examining the effectiveness of aggressive ...
A new study published in the Journal of the American Medical Association reaffirms previous findings about the diabetes drug Avandia—that is, it carries a significantly increased risk of heart failure, heart attack, and death.
Ob...
At the urging of the Food and Drug Administration, GlaxoSmithKline is adding a new warning to its once-popular diabetes drug Avandia . An increased risk of heart attack will now appear in additio...
Copyright © 2001 - 2009 Online Lawyer Source | Legal Marketing Site Designed by eJustice